Clarity Pharmaceuticals Ltd

CHIA:CU6 Stock Report

Market Cap: AU$1.8b

Clarity Pharmaceuticals Future Growth

Future criteria checks 0/6

Clarity Pharmaceuticals is forecast to grow earnings and revenue by 68.2% and 61.5% per annum respectively. EPS is expected to grow by 64% per annum. Return on equity is forecast to be 8.5% in 3 years.

Key information

68.2%

Earnings growth rate

64.0%

EPS growth rate

Pharmaceuticals earnings growth49.1%
Revenue growth rate61.5%
Future return on equity8.5%
Analyst coverage

Low

Last updated04 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

CHIA:CU6 - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202761-3-14-131
6/30/202628-311122
6/30/2025N/A-49-52-512
6/30/202412-42-44-43N/A
3/31/202410-36-41-40N/A
12/31/20239-31-38-38N/A
9/30/202310-28-33-33N/A
6/30/202310-25-28-27N/A
3/31/202310-23-24-24N/A
12/31/20229-21-21-21N/A
9/30/20228-23-17-17N/A
6/30/20226-24-14-13N/A
3/31/20226-21-13-13N/A
12/31/20215-19-12-12N/A
9/30/20214-15-10-10N/A
6/30/20213-10-8-8N/A
3/31/20213-9-7-7N/A
12/31/20203-9-7-7N/A
9/30/20203-8-7-7N/A
6/30/20203-7-7-7N/A
6/30/20193-4-4-4N/A
6/30/20182-2-2-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CU6 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CU6 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CU6 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CU6 is forecast to have no revenue next year.

High Growth Revenue: CU6 is forecast to have no revenue next year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CU6's Return on Equity is forecast to be low in 3 years time (8.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y